Literature DB >> 26971842

Histopathology of NET: Current concepts and new developments.

Anja M Schmitt1, Annika Blank2, Ilaria Marinoni3, Paul Komminoth4, Aurel Perren5.   

Abstract

The diagnosis of neuroendocrine tumors is based on their histopathologic appearance and immunohistochemical profile. With the WHO 2010 classification formal staging and grading was introduced for gastro-entero-pancreatic NET, however, the nomenclature for lung neuroendocrine tumors still relies on the carcinoid term. In this review we also focus on the situation of neuroendocrine carcinoma of unknown primary, tissue biomarkers and actual controversies in the histopathology of NEN.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NEC; NET; WHO; biomarker; carcinoid; classification; grading; histopathology; immunohistochemistry; neuroendocrine tumor

Mesh：

Substances：

Year:  2016        PMID： 26971842     DOI： 10.1016/j.beem.2016.02.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN： 1521-690X            Impact factor:   4.690


  7 in total

Review 1.  Pathology of Neuroendocrine Tumours of the Female Genital Tract.

Authors:  Brooke E Howitt; Paul Kelly; W Glenn McCluggage
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

2.  Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Mohammed B Allaw; Jeffrey M Switchenko; Lana Khalil; Christina Wu; Olatunji B Alese; Mehmet Akce; Amber Draper; Aaron T Jones; Bassel El-Rayes; Walid Shaib
Journal:  Oncology       Date:  2022-01-25       Impact factor: 3.734

Review 3.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 4.  [Grading of neuroendocrine tumors].

Authors:  W Saeger; P A Schnabel; P Komminoth
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

5.  Intestinal differentiated mucinous adenocarcinoma of the endometrium with sporadic MSI high status: a case report.

Authors:  Mafalda Trippel; Sara Imboden; Andrea Papadia; Michael D Mueller; Nando Mertineit; Kirsi Härmä; Alina Nicolae; Erik Vassella; Tilman T Rau
Journal:  Diagn Pathol       Date:  2017-05-12       Impact factor: 2.644

6.  Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer.

Authors:  Bing Guan; Ning Zhou; Cheng-Yang Wu; Songye Li; Yu-An Chen; Sashi Debnath; Mia Hofstad; Shihong Ma; Ganesh V Raj; Dalin He; Jer-Tsong Hsieh; Yiyun Huang; Guiyang Hao; Xiankai Sun
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

7.  PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.

Authors:  Satu Maria Remes; Helena Leijon; Tiina Vesterinen; Johanna Louhimo; Ville Pulkkinen; Sini Ezer; Juha Kere; Caj Haglund; Johanna Arola
Journal:  APMIS       Date:  2020-09-28       Impact factor: 3.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.